Strides Pharma Science Management
Management criteria checks 2/4
Strides Pharma Science's CEO is Arun Pillai, appointed in Apr 2022, has a tenure of 33.83 years. total yearly compensation is ₹60.00M, comprised of 0% salary and 100% bonuses, including company stock and options. directly owns 2.11% of the company’s shares, worth ₹1.70B. The average tenure of the management team and the board of directors is 4.6 years and 8.3 years respectively.
Key information
Arun Pillai
Chief executive officer
₹60.0m
Total compensation
| CEO salary percentage | 0.0% |
| CEO tenure | 2yrs |
| CEO ownership | 2.1% |
| Management average tenure | 4.6yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)
Apr 04
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Feb 29Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story
Dec 23We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt
Sep 26Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Jun 08Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 02Is Strides Pharma Science (NSE:STAR) A Risky Investment?
Jun 25Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?
Dec 21Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50
Jul 28Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)
Apr 13Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?
Mar 04These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively
Feb 15Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?
Jan 26The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It
Jan 11
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?
Dec 28Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 10Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?
Nov 25Insider Buying: The Strides Pharma Science Limited (NSE:STAR) Non-Executive Director Just Bought 52% More Shares
Aug 17What You Can Learn From Strides Pharma Science Limited's (NSE:STAR) P/E
Aug 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -₹2b |
| Sep 30 2023 | n/a | n/a | -₹2b |
| Jun 30 2023 | n/a | n/a | -₹924m |
| Mar 31 2023 | ₹60m | ₹1 | -₹2b |
| Dec 31 2022 | n/a | n/a | -₹2b |
| Sep 30 2022 | n/a | n/a | -₹2b |
| Jun 30 2022 | n/a | n/a | -₹4b |
| Mar 31 2022 | ₹800k | n/a | -₹5b |
| Dec 31 2021 | n/a | n/a | -₹4b |
| Sep 30 2021 | n/a | n/a | -₹3b |
| Jun 30 2021 | n/a | n/a | -₹543m |
| Mar 31 2021 | ₹8m | n/a | ₹3b |
| Dec 31 2020 | n/a | n/a | ₹28m |
| Sep 30 2020 | n/a | n/a | ₹589m |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹72m | ₹49m | ₹492m |
| Dec 31 2019 | n/a | n/a | ₹3b |
| Sep 30 2019 | n/a | n/a | ₹2b |
| Jun 30 2019 | n/a | n/a | ₹745m |
| Mar 31 2019 | ₹50m | ₹38m | ₹840m |
| Dec 31 2018 | n/a | n/a | -₹93m |
| Sep 30 2018 | n/a | n/a | ₹139m |
| Jun 30 2018 | n/a | n/a | ₹415m |
| Mar 31 2018 | ₹106m | ₹14m | ₹544m |
Compensation vs Market: Arun's total compensation ($USD719.46K) is above average for companies of similar size in the Indian market ($USD381.51K).
Compensation vs Earnings: Arun's compensation has increased whilst the company is unprofitable.
CEO
Arun Pillai (62 yo)
2yrs
Tenure
₹60,000,001
Compensation
Mr. Arun Kumar Pillai, B.Com., is Founder of Solara Active Pharma Sciences Limited and serves as its Non-Executive Director since August 04, 2021 and its Founder. Mr. Pillai has been Executive Chairperson...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 2yrs | ₹60.00m | 2.11% ₹ 1.7b | |
| Group CFO | 10.7yrs | ₹44.00m | 0.027% ₹ 21.9m | |
| Compliance Officer & Company Secretary | 7.2yrs | ₹5.86m | no data | |
| Chief Operating Officer | less than a year | no data | no data | |
| Group General Counsel & Chief Risk Officer | no data | no data | no data | |
| Executive Vice President of Operations | no data | no data | no data | |
| Senior Vice President of Strides Pharma Inc. | no data | no data | no data | |
| Chief Quality Officer | no data | no data | no data | |
| Chief Information Technology Officer | no data | no data | no data | |
| Senior Vice President of Institutional Business | no data | no data | no data | |
| Senior Vice President of Regulated Markets | no data | no data | no data | |
| Senior Vice President of Taxation | no data | no data | no data |
4.6yrs
Average Tenure
Experienced Management: STAR's management team is considered experienced (4.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 33.8yrs | ₹60.00m | 2.11% ₹ 1.7b | |
| Group CFO | 6.9yrs | ₹44.00m | 0.027% ₹ 21.9m | |
| Independent Director | 6.9yrs | ₹2.20m | no data | |
| Independent Director | 11.8yrs | ₹2.20m | no data | |
| Executive Chairman of Arrow Pharmaceuticals Pty Ltd | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.8yrs | ₹2.20m | 0.083% ₹ 67.0m | |
| Independent Director | 4.3yrs | ₹2.20m | 0.0013% ₹ 1.1m |
8.3yrs
Average Tenure
72yo
Average Age
Experienced Board: STAR's board of directors are considered experienced (8.3 years average tenure).